MMP14 and breast carcinoma: The expression of MT1-MMP is associated with poor prognosis in patients with advanced neuroblastoma, small cell lung cancer, tongue squamous cell carcinoma, head and neck carcinoma, bladder cancer, breast cancer, and ovarian cancer [9,10].